Wang et al. (2010b), though inconclusively, found that STEAP2 may influence the progression of prostate cancer by activating the extracellular signal–regulated kinase signaling pathway, the mitogen-activated protein kinase (MAPK) pathway, cell cycle progression, and inhibition of apoptosis pathways. Here, STEAP2 is linked to prostate carcinoma.